Clinical Trials Browser

Phase 2 × OTHER × sotigalimab × Clear all

NCT04130854 2026-01-28

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

NCT03719430 2025-04-29

APX005M and Doxorubicin in Advanced Sarcoma

Phase 2 Active not recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

NCT05201001 2023-09-11

APX005M

Phase 2 Withdrawn

Ovarian Neoplasms